Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Definitive Healthcare Corp(DH)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for DH
11/05/2026: DH (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Definitive Healthcare is a provider of data-driven intelligence and analytics for the healthcare sector, offering a subscription platform that helps organizations navigate provider and patient landscapes. The company's core strength lies in its proprietary, granular healthcare data, which serves as a critical resource for its life sciences and medical device clients. While it maintains a leading position in niche commercial intelligence, growth has recently moderated, reflecting industry-wide IT budget constraints. Key risks include intense competition, customer concentration in the pharmaceutical sector, and the need to execute successfully on a pivot toward profitability. The stock may suit growth-oriented investors interested in the digital transformation of healthcare, provided they monitor the firm's ability to diversify its revenue base.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | The company is in a transition phase with moderated growth, making it a speculative growth play. |
| Momentum investor | Weak fit | The stock has lacked consistent upward momentum, making it a weak fit until technical signals improve. |
| Value investor | Mixed fit | Valuation has compressed significantly, but fundamental stability needs to be proven. |
| Dividend investor | Weak fit | The company does not pay a dividend and focuses on reinvestment. |
| Low-risk investor | Weak fit | High volatility and sensitivity to industry spending cycles make it unsuitable for conservative investors. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock has exhibited significant price swings common with growth-stage SaaS equities. |
| Valuation risk | Medium | Market sentiment regarding SaaS multiples can significantly impact the stock price regardless of performance. |
| Competition risk (AI competition) | Medium / high | New AI-driven data entrants could commoditize basic intelligence offerings. |
| Business quality | Medium | The business model is solid, but growth has slowed, affecting the overall franchise perception. |
| Dividend income | Low / none | Investors should expect zero income contribution from this stock. |
| Execution risk | Medium | The company must successfully execute its pivot to profitability and new market expansion. |
Price Behavior
Steep Decline
The stock price has dropped sharply with strong downward pressure.
Highly Choppy
The stock has experienced frequent, large price swings that make its near-term movement less predictable.
Analysis of Past Performance
Type Stock | Historic Profit -54.59% | Avg. Invested days 19 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating  | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 11/05/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 131.30M USD | Price to earnings Ratio - | 1Y Target Price 1.62 |
Price to earnings Ratio - | 1Y Target Price 1.62 | ||
Volume (30-day avg) 435.1K shares | Beta 1.36 | 52 Weeks Range 0.61 - 3.00 | Updated Date 11/05/2026 |
52 Weeks Range 0.61 - 3.00 | Updated Date 11/05/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.61 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Subscription Services | Access fees for the core Definitive Healthcare data and analytics platform. | The company earns the vast majority of its money through recurring monthly or annual subscription contracts. |
| Services and Other | Consulting, advisory, and specialized data integration projects. | These are non-recurring services that support clients in using the platform effectively. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2026-11-05 | When After Market | Estimate 0.01 | Actual - |
Profitability
Profit Margin -72.28% | Operating Margin (TTM) -8.55% |
Management Effectiveness
Return on Assets (TTM) -1.94% | Return on Equity (TTM) -78.37% |
Valuation
Trailing PE - | Forward PE 6.16 | Enterprise Value 108.35M | Price to Sales(TTM) 0.56 |
Enterprise Value 108.35M | Price to Sales(TTM) 0.56 | ||
Enterprise Value to Revenue 0.47 | Enterprise Value to EBITDA 46.69 | Shares Outstanding 106.74M | Shares Floating 40.43M |
Shares Outstanding 106.74M | Shares Floating 40.43M | ||
Percent Insiders 6.19 | Percent Institutions 82.73 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.